Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Hemond

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|July 22, 2020
Placebos in chronic pain: evidence, theory, ethics, and use in clinical practiceTed J Kaptchuk, Christopher C Hemond, Franklin G Miller
Multiple Sclerosis and Related Disorders|February 24, 2024
Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic ReviewAbigail Bose, Farnaz Khalighinejad, David C Hoaglin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2022
Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional studyChristopher C Hemond, Jonggyu Baek, Carolina Ionete, et al.
Plos One|June 28, 2007
A preference for contralateral stimuli in human object- and face-selective cortexChristopher C Hemond, Nancy G Kanwisher, Hans P Op de Beeck
Neuroimaging Clinics of North America|June 28, 2024
New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein SignChristopher C Hemond, María I Gaitán, Martina Absinta, et al.
BMC Neurology|February 14, 2019
The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosisChristopher C Hemond, Bonnie I Glanz, Rohit Bakshi, et al.
Brain and Behavior|July 19, 2018
Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosisChristopher C Hemond, Renxin Chu, Subhash Tummala, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparisonChris Hollen, Carolina Garcia, Christopher C Hemond, et al.
Multiple Sclerosis and Related Disorders|November 14, 2020
A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosisJorge Acevedo Herman, Farnaz Khalighinejad, Katherine York, et al.
Journal of Investigative Medicine High Impact Case Reports|July 26, 2021
Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From MetastasesChristopher C Hemond, Rohit Bakshi, Shahamat Tauhid, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|July 22, 2020
Placebos in chronic pain: evidence, theory, ethics, and use in clinical practiceTed J Kaptchuk, Christopher C Hemond, Franklin G Miller
Multiple Sclerosis and Related Disorders|February 24, 2024
Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic ReviewAbigail Bose, Farnaz Khalighinejad, David C Hoaglin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2022
Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional studyChristopher C Hemond, Jonggyu Baek, Carolina Ionete, et al.
Plos One|June 28, 2007
A preference for contralateral stimuli in human object- and face-selective cortexChristopher C Hemond, Nancy G Kanwisher, Hans P Op de Beeck
Neuroimaging Clinics of North America|June 28, 2024
New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein SignChristopher C Hemond, María I Gaitán, Martina Absinta, et al.
BMC Neurology|February 14, 2019
The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosisChristopher C Hemond, Bonnie I Glanz, Rohit Bakshi, et al.
Brain and Behavior|July 19, 2018
Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosisChristopher C Hemond, Renxin Chu, Subhash Tummala, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparisonChris Hollen, Carolina Garcia, Christopher C Hemond, et al.
Multiple Sclerosis and Related Disorders|November 14, 2020
A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosisJorge Acevedo Herman, Farnaz Khalighinejad, Katherine York, et al.
Journal of Investigative Medicine High Impact Case Reports|July 26, 2021
Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From MetastasesChristopher C Hemond, Rohit Bakshi, Shahamat Tauhid, et al.
Pageof 4